Download Free Sample Report

Global and United States Lung Cancer Liquid Biops Market Report & Forecast 2022-2028

Global and United States Lung Cancer Liquid Biops Market Report & Forecast 2022-2028

  • Published on : 10 October 2022
  • Pages :122
  • Report Code:SMR-7430494

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

Lung Cancer Liquid Biops market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Lung Cancer Liquid Biops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Lung Cancer Liquid Biops market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Exosomes and RNA
CTCs and ctDNA
Segment by Application
Hospitals and Clinics
Physicians'Office Laboratories
Clinical Diagnostic Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine